IP Library › Patent Application 13802387
Patent Application
App. No. 13/802,387

CATHETER HAVING ANTIMICROBIAL COATING

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/802,387
Abstract

A catheter for human or animal vascular engagement is provided. The catheter has at least one interior lumen defined by a sidewall having an exterior circumferential. A titanium surface area is positioned along the circumferential surface entirely or at one or both ends to enhance lubricity. Additionally included may be an anti pathogenic and/or anti microbial surface area positioned adjacent to the titanium surface area of the circumferential surface.

Claims (43)

1 . An improved catheter comprising:

said catheter having at least one interior lumen defined by a sidewall forming said catheter, said sidewall having an exterior circumferential surface extending between a first end of said catheter and a second end of said catheter; and

a titanium surface area communicating along said circumferential surface, said titanium surface area defining a means for inhibiting pathogens and a means for enhancing lubricity with tissue contacting said circumferential surface thereby providing prevention of tissue adherence thereto.

2 . The improved catheter of claim 1 additionally comprising:

said titanium surface area covering all of said circumferential surface.

3 . The improved catheter of claim 1 additionally comprising:

said titanium surface area positioned upon said circumferential surface extending a distance toward a central portion of said catheter, from one or both of said first end and said second end.

4 . The improved catheter of claim 1 additionally comprising:

an anti pathogenic and/or anti microbial surface area positioned adjacent to said titanium surface area upon said circumferential surface.

5 . The improved catheter of claim 2 additionally comprising:

an anti pathogenic and/or anti microbial surface area positioned adjacent to said titanium surface area upon said circumferential surface.

6 . The improved catheter of claim 2 additionally comprising:

an anti pathogenic and/or anti microbial surface area positioned adjacent to said titanium surface upon said circumferential surface at one or both of said first end and said second end.

7 . The improved catheter of claim 3 additionally comprising:

an anti pathogenic and/or anti microbial surface area positioned adjacent to said titanium surface area upon said circumferential surface at one or both of said first end and said second end.

8 . The improved catheter of claim 1 additionally comprising:

said catheter terminating on said first end along a first distal edge normal to said circumferential edge;

said catheter terminating on said second end along a second distal edge normal to said circumferential edge; and

said titanium surface area also positioned upon said first distal edge and said second distal edge to thereby improve lubricity thereof to provide a means for inhibiting tissue engagement thereto.

9 . The improved catheter of claim 2 additionally comprising:

said catheter terminating on said first end along a first distal edge normal to said circumferential edge;

said catheter terminating on said second end along a second distal edge normal to said circumferential edge; and

said titanium surface area also positioned upon said first distal edge and said second distal edge to thereby improve lubricity thereof to provide a means for inhibiting tissue engagement thereto.

10 . The improved catheter of claim 3 additionally comprising:

said catheter terminating on said first end along a first distal edge normal to said circumferential edge;

said catheter terminating on said second end along a second distal edge normal to said circumferential edge; and

said titanium surface area also positioned upon said first distal edge and said second distal edge to thereby improve lubricity thereof to provide a means for inhibiting tissue engagement thereto.

11 . The improved catheter of claim 4 additionally comprising:

said catheter terminating on said first end along a first distal edge normal to said circumferential edge;

said catheter terminating on said second end along a second distal edge normal to said circumferential edge; and

said titanium surface area also positioned upon said first distal edge and said second distal edge to thereby improve lubricity thereof to provide a means for inhibiting tissue engagement thereto.

12 . The improved catheter of claim 5 additionally comprising:

said catheter terminating on said first end along a first distal edge normal to said circumferential edge;

said catheter terminating on said second end along a second distal edge normal to said circumferential edge; and

said titanium surface area also positioned upon said first distal edge and said second distal edge to thereby improve lubricity thereof to provide a means for inhibiting tissue engagement thereto.

13 . The improved catheter of claim 6 additionally comprising:

said catheter terminating on said first end along a first distal edge normal to said circumferential edge;

said catheter terminating on said second end along a second distal edge normal to said circumferential edge; and

said titanium surface area also positioned upon said first distal edge and said second distal edge to thereby improve lubricity thereof to provide a means for inhibiting tissue engagement thereto.

14 . The improved catheter of claim 7 additionally comprising:

said catheter terminating on said first end along a first distal edge normal to said circumferential edge;

said catheter terminating on said second end along a second distal edge normal to said circumferential edge; and

said titanium surface area also positioned upon said first distal edge and said second distal edge to thereby improve lubricity thereof to provide a means for inhibiting tissue engagement thereto.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2015
From: KERR, MARSHALL
To: PFM MEDICAL, INC.
Reel/Frame 035702/0606 →